家庭住院代表了传统住院的替代方案,为血液学患者提供可比的临床安全性。家庭治疗可以从静脉注射抗生素到更复杂的情况,如造血干细胞移植和嵌合抗原受体T细胞治疗后早期的护理。从常规住院早期出院是可行的,并有助于减少医院资源和等待名单。多学科小组的协调努力,包括血液学家,护士,药剂师,确保患者的安全和护理的连续性。传统的家庭住院模式依赖于家访和与医生和护士的电话咨询。然而,使用电子健康技术,比如MY-Meedura,可以加强沟通和监控,从而改善患者的治疗效果,无需额外费用。临床药师积极参与家庭住院计划至关重要,不仅为了药物的适当后勤管理,而且为了确保其适当性,优化治疗,来自团队和患者的地址查询,促进坚持。总之,实施造血干细胞移植和嵌合抗原受体T细胞治疗家庭住院计划,使用电子健康工具和多学科护理模式,可以优化患者护理并提高生活质量,而不会增加医疗保健成本。
Home hospitalization represents an alternative to traditional hospitalization, providing comparable clinical safety for hematological patients. At-home therapies can range from the delivery of intravenous antibiotics to more complex scenarios, such as the care during the early period after hematopoietic stem cell transplantation and chimeric antigen receptor T-cell therapy. Early discharge from conventional hospitalization is feasible and helps reduce hospital resources and waiting lists. The coordinated efforts of multidisciplinary teams, including hematologists, nurses, and pharmacists, ensure patient safety and continuity of care. The traditional model of home hospitalization relies on home visits and telephone consultations with physicians and nurses. However, the use of eHealth technologies, such as MY-Medula, can enhance communication and monitoring, and thereby improve patient outcomes with no additional costs. The active involvement of a clinical pharmacist in home hospitalization programs is essential, not only for the proper logistical management of the medication but also to ensure its appropriateness, optimize treatment, address queries from the team and patients, and promote adherence. In conclusion, the implementation of hematopoietic stem cell transplantation and chimeric antigen receptor T-cell therapy home hospitalization programs that use both an eHealth tool and a multidisciplinary care model can optimize patient care and improve quality of life without increasing healthcare costs.